Hydreight Technologies Expands Telehealth Offerings with Launch of NAD+ Therapy on VSDHOne Platform

Stock Information for Victory Square Technologies Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Victory Square Technologies Inc

Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets
Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook
Victory Square Technologies Reports Q3 2025 Financial Results & Provides Corporate Update
CSE Bulletin: MOC Eligibility Update
Victory Square Technologies to Launch Share Buyback (NCIB) as Balance Sheet Clears; Announces NAV-Focused Investor Webinar
Hydreight Posts Record VSDHOne Growth and Outperforms Internal Projections
Hydreight Technologies Signs Binding Letter of Intent to Acquire Dynamic IV Therapy Support AI Agent
Hydreight Technologies Signs Definitive Agreement to Acquire 5% Equity Stake in Perfect Scripts, LLC, with Option to Increase to 40%, and Establish Strategic Partnership

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.